InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,732.93
(
0.25%
)
US TECH 100
19,426.00
(
0.54%
)
Dow Jones
42,208.22
(
0.20%
)
Brent Oil
74.32
(
-0.33%
)
Bitcoin
64,294.00
(
0.04%
)
Post# of 1484
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Diogenes of Sinope

Send PM Follow Ignore
Followers 498
Posts 29613
Boards Moderated 4
Alias Born 06/17/2010

Diogenes of Sinope

Member Level

Re: None

Monday, 10/29/2018 11:06:03 PM

Monday, October 29, 2018 11:06:03 PM

Post# of 1484
AusCann on Track for Launch of Validated Cannabinoid Medicines in 2019

Completion of successful pilot production of AusCann’s final dose form cannabinoid hard shell capsules

• This success enables the move of the production process into a commercial facility in preparation for Australian market and export supply in 2019

• These medicines will then be taken through AusCann’s clinical development program for registration of an approved cannabinoid pain management pharmaceutical product

• Well-funded to execute on its growth strategy following A$35 million Placement during the quarter


http://www.finnewsnetwork.com.au/CompanyReports/Auscann-Group-Holdings/AusCann-on-Track-for-Launch-of-Validated-Cannabinoid-Medicines-in-2019

GLTA!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up